These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 25942722)

  • 1. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
    Gerding DN; Meyer T; Lee C; Cohen SH; Murthy UK; Poirier A; Van Schooneveld TC; Pardi DS; Ramos A; Barron MA; Chen H; Villano S
    JAMA; 2015 May; 313(17):1719-27. PubMed ID: 25942722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-toxigenic
    Gerding DN; Sambol SP; Johnson S
    Front Microbiol; 2018; 9():1700. PubMed ID: 30093897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.
    Villano SA; Seiberling M; Tatarowicz W; Monnot-Chase E; Gerding DN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5224-9. PubMed ID: 22850511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Colonization by Nontoxigenic Clostridioides difficile REA Strain M3 (NTCD-M3) Spores following Treatment with Either Fidaxomicin or Vancomycin.
    Sambol SP; Skinner AM; Serna-Perez F; Owen B; Gerding DN; Johnson S
    Microbiol Spectr; 2023 Mar; 11(2):e0051723. PubMed ID: 36975811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.
    Youngster I; Russell GH; Pindar C; Ziv-Baran T; Sauk J; Hohmann EL
    JAMA; 2014 Nov; 312(17):1772-8. PubMed ID: 25322359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.
    Lee CH; Steiner T; Petrof EO; Smieja M; Roscoe D; Nematallah A; Weese JS; Collins S; Moayyedi P; Crowther M; Ropeleski MJ; Jayaratne P; Higgins D; Li Y; Rau NV; Kim PT
    JAMA; 2016 Jan; 315(2):142-9. PubMed ID: 26757463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.
    Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.
    Louie T; Golan Y; Khanna S; Bobilev D; Erpelding N; Fratazzi C; Carini M; Menon R; Ruisi M; Norman JM; Faith JJ; Olle B; Li M; Silber JL; Pardi DS
    JAMA; 2023 Apr; 329(16):1356-1366. PubMed ID: 37060545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
    Hota SS; Sales V; Tomlinson G; Salpeter MJ; McGeer A; Coburn B; Guttman DS; Low DE; Poutanen SM
    Clin Infect Dis; 2017 Feb; 64(3):265-271. PubMed ID: 28011612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
    Cornely OA; Crook DW; Esposito R; Poirier A; Somero MS; Weiss K; Sears P; Gorbach S;
    Lancet Infect Dis; 2012 Apr; 12(4):281-9. PubMed ID: 22321770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
    N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C
    Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.
    Nagaro KJ; Phillips ST; Cheknis AK; Sambol SP; Zukowski WE; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5266-70. PubMed ID: 23939887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on treatment outcomes in Clostridium difficile infection.
    Louie TJ; Miller MA; Crook DW; Lentnek A; Bernard L; High KP; Shue YK; Gorbach SL
    J Am Geriatr Soc; 2013 Feb; 61(2):222-30. PubMed ID: 23379974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.
    Dubberke ER; Lee CH; Orenstein R; Khanna S; Hecht G; Gerding DN
    Clin Infect Dis; 2018 Sep; 67(8):1198-1204. PubMed ID: 29617739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline for the treatment of severe Clostridium difficile infection.
    Larson KC; Belliveau PP; Spooner LM
    Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
    Musher DM; Logan N; Bressler AM; Johnson DP; Rossignol JF
    Clin Infect Dis; 2009 Feb; 48(4):e41-6. PubMed ID: 19133801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.